These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9250482)

  • 21. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.
    Walsh KB; Edwards RA; Romero KM; Kotlajich MV; Stohlman SA; Lane TE
    J Immunol; 2007 Jul; 179(2):1155-65. PubMed ID: 17617609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia.
    Roth-Cross JK; Bender SJ; Weiss SR
    J Virol; 2008 Oct; 82(20):9829-38. PubMed ID: 18667505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute hepatic failure in IFN-gamma-deficient BALB/c mice after murine coronavirus infection.
    Kyuwa S; Shibata S; Tagawa Y; Iwakura Y; Machii K; Urano T
    Virus Res; 2002 Feb; 83(1-2):169-77. PubMed ID: 11864749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Difference in response to mouse hepatitis virus among susceptible mouse strains.
    Taguchi F; Hirano N; Kiuchi Y; Fujiwara K
    Jpn J Microbiol; 1976 Aug; 20(4):293-302. PubMed ID: 185441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interference of natural mouse hepatitis virus infection with cytokine production and susceptibility to Trypanosoma cruzi.
    Torrecilhas AC; Faquim-Mauro E; Da Silva AV; Abrahamsohn IA
    Immunology; 1999 Mar; 96(3):381-8. PubMed ID: 10233719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
    Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse hepatitis virus and host determinants of vertical transmission and maternally-derived passive immunity in mice.
    Barthold SW; Beck DS; Smith AL
    Arch Virol; 1988; 100(3-4):171-83. PubMed ID: 2840871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection.
    Cervantes-Barragán L; Kalinke U; Züst R; König M; Reizis B; López-Macías C; Thiel V; Ludewig B
    J Immunol; 2009 Jan; 182(2):1099-106. PubMed ID: 19124753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enterotropic coronavirus (mouse hepatitis virus) in mice: influence of host age and strain on infection and disease.
    Barthold SW; Beck DS; Smith AL
    Lab Anim Sci; 1993 Aug; 43(4):276-84. PubMed ID: 8231082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.
    Fingerote RJ; Abecassis M; Phillips MJ; Rao YS; Cole EH; Leibowitz J; Levy GA
    J Virol; 1996 Jul; 70(7):4275-82. PubMed ID: 8676449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptor-2 exacerbates murine acute viral hepatitis.
    Bleau C; Burnette M; Filliol A; Piquet-Pellorce C; Samson M; Lamontagne L
    Immunology; 2016 Oct; 149(2):204-24. PubMed ID: 27273587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of resistant A/J mice with methylprednisolone (MP) results in loss of resistance to murine hepatitis strain 3 (MHV-3) and induction of macrophage procoagulant activity (PCA).
    Fingerote RJ; Leibowitz JL; Rao YS; Levy GA
    Adv Exp Med Biol; 1995; 380():89-94. PubMed ID: 8830551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM.
    Smith AL; Barthold SW; de Souza MS; Bottomly K
    Arch Virol; 1991; 121(1-4):89-100. PubMed ID: 1662041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitis.
    Muse M; Kane JA; Carr DJ; Farber JM; Lane TE
    Virology; 2008 Dec; 382(2):132-44. PubMed ID: 18973912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and long-term in vivo immune dysfunction after infection of BALB/c mice with mouse hepatitis virus strain A59.
    Cray C; Mateo MO; Altman NH
    Lab Anim Sci; 1993 Apr; 43(2):169-74. PubMed ID: 8100597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of macrophage source and activation on susceptibility in an age-dependent model of murine hepatitis caused by a phlebovirus, Punta Toro.
    Latham PS; Sepelak SB
    Arch Virol; 1992; 122(1-2):175-85. PubMed ID: 1370368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levo-1-methyl tryptophan aggravates the effects of mouse hepatitis virus (MHV-A59) infection.
    Duhalde Vega M; Aparício JL; Retegui LA
    Int Immunopharmacol; 2015 Feb; 24(2):377-382. PubMed ID: 25573404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection.
    Li C; Fung LS; Chung S; Crow A; Myers-Mason N; Phillips MJ; Leibowitz JL; Cole E; Ottaway CA; Levy G
    J Exp Med; 1992 Sep; 176(3):689-97. PubMed ID: 1324969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus.
    Glass WG; Liu MT; Kuziel WA; Lane TE
    Virology; 2001 Sep; 288(1):8-17. PubMed ID: 11543653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.